Adaptive treatment margins to reduce organs at risk dose in patients with no or minimal anatomical changes in radiotherapy of non-small cell lung cancer

Abstract

Background and purpose

In non-small cell lung cancer (NSCLC) a significant portion of the planning target volume (PTV) margin accommodates for anatomical changes during treatment. Patients with no or minimal anatomical changes might therefore benefit from a reduced PTV margin, resulting in lower organ at risk (OAR) doses. We evaluated a plan of the day approach using different PTV margins to quantify its effect on OAR and clinical target volume (CTV) dose.

Materials and methods

Twenty NSCLC patients were included in this retrospective study. CBCTs of all fractions were evaluated using an image-guided radiotherapy (IGRT) protocol to classify fractions into two groups: no or minimal anatomical changes to which reduced PTV margin plans (5 or 2 mm) were assigned, or with anatomical changes that received the reference treatment plan (8 mm PTV margin). OAR doses were investigated and CTV coverage was evaluated using CBCT dose recalculations.

Results

All plans showed decreased OAR dose when the PTV margin was reduced from 8 mm to 5 mm or 2 mm. The IGRT protocol selected 254/600 fractions in 19/20 patients, that could be treated with a smaller margin. CTV V_95% remained ≥95% in 94% of the 5 mm plans and 87% of the 2 mm plans, compared to 98% of the reference 8 mm plans.

Conclusion

The IGRT protocol could identify fractions with no or minimal anatomical changes allowing a plan of the day approach to reduce PTV margins. Target coverage remained adequate in the majority of patients, while reducing OAR doses.